Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,084 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Biological brain age prediction using machine learning on structural neuroimaging data: Multi-cohort validation against biomarkers of Alzheimer's disease and neurodegeneration stratified by sex.
Cumplido-Mayoral I, García-Prat M, Operto G, Falcon C, Shekari M, Cacciaglia R, Milà-Alomà M, Lorenzini L, Ingala S, Meije Wink A, Mutsaerts HJMM, Minguillón C, Fauria K, Molinuevo JL, Haller S, Chetelat G, Waldman A, Schwarz AJ, Barkhof F, Suridjan I, Kollmorgen G, Bayfield A, Zetterberg H, Blennow K, Suárez-Calvet M, Vilaplana V, Gispert JD; ALFA study; EPAD study; ADNI study; OASIS study. Cumplido-Mayoral I, et al. Among authors: blennow k. Elife. 2023 Apr 17;12:e81067. doi: 10.7554/eLife.81067. Elife. 2023. PMID: 37067031 Free PMC article.
Genetically predicted telomere length and Alzheimer's disease endophenotypes: a Mendelian randomization study.
Rodríguez-Fernández B, Vilor-Tejedor N, Arenaza-Urquijo EM, Sánchez-Benavides G, Suárez-Calvet M, Operto G, Minguillón C, Fauria K, Kollmorgen G, Suridjan I, de Moura MC, Piñeyro D, Esteller M, Blennow K, Zetterberg H, De Vivo I, Molinuevo JL, Navarro A, Gispert JD, Sala-Vila A, Crous-Bou M; ALFA study. Rodríguez-Fernández B, et al. Among authors: blennow k. Alzheimers Res Ther. 2022 Nov 7;14(1):167. doi: 10.1186/s13195-022-01101-9. Alzheimers Res Ther. 2022. PMID: 36345036 Free PMC article.
Brain-derived tau: a novel blood-based biomarker for Alzheimer's disease-type neurodegeneration.
Gonzalez-Ortiz F, Turton M, Kac PR, Smirnov D, Premi E, Ghidoni R, Benussi L, Cantoni V, Saraceno C, Rivolta J, Ashton NJ, Borroni B, Galasko D, Harrison P, Zetterberg H, Blennow K, Karikari TK. Gonzalez-Ortiz F, et al. Among authors: blennow k. Brain. 2023 Mar 1;146(3):1152-1165. doi: 10.1093/brain/awac407. Brain. 2023. PMID: 36572122 Free PMC article.
Exploring cognitive and biological correlates of sleep quality and their potential links with Alzheimer's disease (ALFASleep project): protocol for an observational study.
Fauria K, Minguillon C, Knezevic I, Tort-Colet N, Stankeviciute L, Hernández L, Rădoi A, Deulofeu C, Fuentes-Julián S, Turull I, Fusté D, Sánchez-Benavides G, Arenaza-Urquijo EM, Suárez-Calvet M, Holst SC, Garcés P, Mueggler T, Zetterberg H, Blennow K, Arqueros A, Iranzo Á, Domingo Gispert J, Molinuevo JL, Grau-Rivera O. Fauria K, et al. Among authors: blennow k. BMJ Open. 2022 Dec 30;12(12):e067159. doi: 10.1136/bmjopen-2022-067159. BMJ Open. 2022. PMID: 36585141 Free PMC article.
Plasma biomarker profiles in autosomal dominant Alzheimer's disease.
Johansson C, Thordardottir S, Laffita-Mesa J, Rodriguez-Vieitez E, Zetterberg H, Blennow K, Graff C. Johansson C, et al. Among authors: blennow k. Brain. 2023 Mar 1;146(3):1132-1140. doi: 10.1093/brain/awac399. Brain. 2023. PMID: 36626935 Free PMC article.
The recency ratio assessed by story recall is associated with cerebrospinal fluid levels of neurodegeneration biomarkers.
Bruno D, Jauregi Zinkunegi A, Kollmorgen G, Suridjan I, Wild N, Carlsson C, Bendlin B, Okonkwo O, Chin N, Hermann BP, Asthana S, Zetterberg H, Blennow K, Langhough R, Johnson SC, Mueller KD. Bruno D, et al. Among authors: blennow k. Cortex. 2023 Feb;159:167-174. doi: 10.1016/j.cortex.2022.12.004. Epub 2022 Dec 23. Cortex. 2023. PMID: 36630749 Free PMC article.
Optimal combinations of CSF biomarkers for predicting cognitive decline and clinical conversion in cognitively unimpaired participants and mild cognitive impairment patients: A multi-cohort study.
Salvadó G, Larsson V, Cody KA, Cullen NC, Jonaitis EM, Stomrud E, Kollmorgen G, Wild N, Palmqvist S, Janelidze S, Mattsson-Carlgren N, Zetterberg H, Blennow K, Johnson SC, Ossenkoppele R, Hansson O. Salvadó G, et al. Among authors: blennow k. Alzheimers Dement. 2023 Jul;19(7):2943-2955. doi: 10.1002/alz.12907. Epub 2023 Jan 17. Alzheimers Dement. 2023. PMID: 36648169
Identifying clinically useful biomarkers in neurodegenerative disease through a collaborative approach: the NeuroToolKit.
Johnson SC, Suárez-Calvet M, Suridjan I, Minguillón C, Gispert JD, Jonaitis E, Michna A, Carboni M, Bittner T, Rabe C, Kollmorgen G, Zetterberg H, Blennow K. Johnson SC, et al. Among authors: blennow k. Alzheimers Res Ther. 2023 Jan 28;15(1):25. doi: 10.1186/s13195-023-01168-y. Alzheimers Res Ther. 2023. PMID: 36709293 Free PMC article.
2,084 results